BUKWANG PHARMACEUTICAL IND CO.,LTD

R&D pharma firm developing drugs for CNS disorders, oncology, and metabolic diseases.

003000 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 서울특별시 동작구 대방동1길 47, 서울특별시
Website:: https://www.bukwang.co.kr/en/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bukwang Pharmaceutical Co., Ltd. is an R&D-focused pharmaceutical company engaged in the development, manufacturing, and commercialization of therapeutic drugs. The company employs an 'open innovation' strategy, utilizing strategic investments, joint ventures, research collaborations, and acquisitions to expand its drug pipeline and enhance its global competitiveness. Its development pipeline targets a range of conditions, with a focus on central nervous system (CNS) disorders such as schizophrenia (Lurasidone) and Parkinson's disease (JM-010), as well as oncology (SOL-804 for prostate cancer), liver diseases, and metabolic disorders. Through continuous research and strategic partnerships, Bukwang aims to become a global pharmaceutical innovator.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for BUKWANG PHARMACEUTICAL IND CO.,LTD and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size
2025-08-29 00:00	Related Party Transaction 대규모기업집단현황공시[분기별공시(개별회사용)]	Korean	10.5 KB
2025-08-14 00:00	Interim Report 반기보고서 (2025.06)	Korean	1.6 MB
2025-08-14 00:00	Regulatory News Service 지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항	Korean	11.3 KB

Automate Your Workflow. Get a real-time feed of all BUKWANG PHARMACEUTICAL IND CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BUKWANG PHARMACEUTICAL IND CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
StemRIM Inc. Developing regenerative medicines that use the body's own stem cells to treat intractable diseases.	Japan	4599
STENOCARE A/S Develops and distributes prescription medical cannabis oils in Northern Europe and Australia.	Denmark	STENO
ST PHARM CO., LTD. A global CDMO specializing in APIs and RNA therapeutics for the gene therapy market.	South Korea	237690
Sugentech, Inc. Develops advanced in-vitro diagnostic systems for hospitals, clinics, and at-home use.	South Korea	253840
SUHEUNG CO.,LTD. Global manufacturer of capsules and contract manufacturing for pharma/nutraceutical industries.	South Korea	008490
Sumitomo Pharma Co., Ltd. R&D pharma creating medicines for oncology, psychiatry & neurology, focusing on Japan & the US.	Japan	4506
SunBio, Inc. Develops biopharmaceuticals and devices like artificial blood using proprietary PEGylation technology.	South Korea	067370
Swedish Orphan Biovitrum Develops innovative therapies for rare diseases in haematology, immunology, and specialty care.	Sweden	SOBI
SymBio Pharmaceuticals Limited Acquires and commercializes specialty drugs for unmet needs in Japan and the Asia-Pacific region.	Japan	4582
SynAct Pharma Biotech developing oral therapies to resolve inflammation in diseases like rheumatoid arthritis.	Sweden	SYNACT